A new study on COVID-19 vaccines that looked at nearly 100 million
Our study is the most comprehensive NMA exploring the efficacy and safety
Methylprednisolone can help with COVID according to a 2022 systematic review of 33 studies that reported the use of methylprednisolone was associated with:
However, there is inconsistency regarding the use of methylprednisolone over dexamethasone in COVID-19, and this has not been extensively evaluated in patients with a history of asthma
Small, Benjamin Stephens, Paloma Sanchez, Moezzullah
It should be noted that the equivalent dose of methylprednisolone used was hig
A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia Signal Transduct Target Ther
Compared with methylprednisolone, treatment with dexamethasone was more effective and decreased the length of hospitalization in patients with COVID-19 infection, according to results of a randomized clinical trial published in the International Journal of Infectious Diseases
Backgrounds: Corona virus disease 19 (Covid-19) affects especially the respiratory tract, and induces lung injury which may progress to the acute respiratory distress syndrome (ARDS)
Background: Recent trials with dexamethasone and hydrocortisone have demonstrated benefit in patients with coronavirus disease 2019 (COVID-19)
Treatment was administered in conjunction with standard of care for 10 days
The study found that methylprednisolone caused a greater reduction in mortality in patients with COVID-19 who needed mechanical ventilation when compared to dexamethasone
However, whether corticosteroids can prevent respiratory worsening in hospitalized COVID-19 patients without oxygen requirements is currently unknown
A significant reduction in the all-cause 28-day
Methods: We conducted a multicentre, open-label RCT to investigate methylprednisolone 80 mg as a continuous daily infusion for 8 days followed by slow tapering versus dexamethasone 6 mg once daily for up to 10 days in adult patients with COVID-19 pneumonia requiring oxygen or noninvasive respiratory support
The complication rate was similar for the 2 groups ( P =